About Omzey
Omzey is a company based in Rome (Italy) founded in 2017 by Nicolo Risitano, Giovanni Stracquadaneo, Simone Gardini, and Alessandro Rossi. Omzey has raised $1.63 million across 4 funding rounds from investors including LVenture Group, European Union and a|impact. Omzey operates in a competitive market with competitors including Helix, Benchling, BioAge Labs, Ingenuity Systems and Cellworks, among others.
- Headquarter Rome, Italy
- Founders Nicolo Risitano, Giovanni Stracquadaneo, Simone Gardini, Alessandro Rossi
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.63 M (USD)
in 4 rounds
-
Latest Funding Round
$121.66 K (USD), Grant
Dec 01, 2022
-
Investors
LVenture Group
& 7 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Omzey
Omzey has successfully raised a total of $1.63M across 4 strategic funding rounds. The most recent funding activity was a Grant round of $121.66 thousand completed in December 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Omzey
Omzey has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include LVenture Group, European Union and a|impact.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Lumen Ventures is engaged in seed stage venture investments.
|
Locked | Locked | Locked | |
|
Pre-seed, seed, and first-stage investments in welfare services are targeted.
|
Locked | Locked | Locked | |
|
An investment company based in Bologna, Italy, is operated.
|
Locked | Locked | Locked |
Investor details for Omzey
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Omzey
Investment portfolio details for Omzey
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Omzey
Detailed financials for Omzey
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Omzey Comparisons
Peer comparison for Omzey
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Omzey
Omzey operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Helix, Benchling, BioAge Labs, Ingenuity Systems and Cellworks, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genomic database for clinical research is provided.
|
|
| Locked | Locked | Locked |
Cloud-based bioinformatics platform is offered for biotech research.
|
|
| Locked | Locked | Locked |
Bioinformatics platform is provided for biomarkers and drug discovery.
|
|
| Locked | Locked | Locked |
Genomic data is analyzed and interpreted via web-based applications.
|
|
| Locked | Locked | Locked |
Biosimulation platform developed for therapeutic design in life sciences.
|
|
| Locked | Locked | Locked |
AI-based omics data analysis solutions are provided to researchers.
|
Detailed competitors of Omzey
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Omzey
Complete news archive for Omzey
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Omzey
Omzey was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Omzey is headquartered in Rome, Italy. It is registered at Rome, Lazio, Italy.
Simone Gardini is the current CEO of Omzey. They have also founded this company.
Omzey is a funded company, having raised a total of $1.63M across 4 funding rounds to date.
Omzey was founded in 2017 and is headquartered in Rome, Italy. The company operates in the diagnostics sector, offering cloud-based solutions for genetics laboratories. Its flagship product, JuliaOmix, is designed to manage the genomic analysis cycle, encompassing processes from sample requests to reporting and clinical decision support. These tools are utilized to streamline laboratory operations and enhance workflow efficiency.
Omzey's top competitors include Helix, Benchling and BioAge Labs.
Omzey has 8 investors. Key investors include LVenture Group, European Union, a|impact, Lumen Ventures, and FINALCA.